share_log

Itron, Inc. (NASDAQ:ITRI) Receives Consensus Recommendation of "Hold" From Analysts

Itron, Inc. (NASDAQ:ITRI) Receives Consensus Recommendation of "Hold" From Analysts

ITRON,Inc.(納斯達克代碼:ITRI)收到分析師一致建議的“持有”
Defense World ·  2022/09/23 02:31

Itron, Inc. (NASDAQ:ITRI – Get Rating) has been given a consensus rating of "Hold" by the twelve ratings firms that are currently covering the stock, MarketBeat Ratings reports. Eight investment analysts have rated the stock with a hold recommendation, one has given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $62.13.

據MarketBeat Ratings報道,目前涵蓋該股的12家評級公司已將Itron,Inc.(納斯達克代碼:ITRI-GET Rating)的一致評級定為“持有”。八名投資分析師對該股的評級為持有建議,一名分析師給出了買入建議,一名分析師給出了強烈的買入建議。過去一年對該股進行評級的分析師的平均1年目標價為62.13美元。

Several brokerages have commented on ITRI. Raymond James lowered their price target on Itron from $72.00 to $68.00 and set a "strong-buy" rating on the stock in a report on Tuesday, July 12th. Morgan Stanley lowered their price target on Itron from $60.00 to $55.00 and set an "equal weight" rating on the stock in a report on Thursday, June 9th. StockNews.com downgraded shares of Itron from a "buy" rating to a "hold" rating in a research note on Friday, August 5th. JPMorgan Chase & Co. downgraded shares of Itron from an "overweight" rating to a "neutral" rating and set a $65.00 price objective on the stock. in a research note on Monday, August 8th. Finally, Stephens downgraded shares of Itron from an "overweight" rating to an "equal weight" rating and lowered their price objective for the stock from $65.00 to $55.00 in a research note on Friday, August 5th.

幾家券商對工研院發表了評論。雷蒙德·詹姆斯在7月12日(星期二)的一份報告中將其對Itron的目標價從72.00美元下調至68.00美元,並對該股設定了“強勢買入”評級。摩根士丹利在6月9日週四的一份報告中將他們對Itron的目標價從60.00美元下調至55.00美元,並對該股設定了“同等權重”的評級。在8月5日星期五的一份研究報告中,StockNews.com將ITRON的股票評級從“買入”下調至“持有”。摩根大通將Itron的股票評級從“增持”下調至“中性”,併為該股設定了65.00美元的目標價。在8月8日星期一的一份研究報告中。最後,斯蒂芬斯在8月5日星期五的一份研究報告中將Itron的股票評級從增持下調至同等權重,並將該股的目標價從65.00美元下調至55.00美元。

Get
到達
Itron
ITRON
alerts:
警報:

Itron Trading Down 2.7 %

ITRON股價下跌2.7%

NASDAQ:ITRI opened at $45.25 on Friday. The stock's 50 day moving average price is $51.02 and its 200 day moving average price is $50.00. Itron has a 52 week low of $43.18 and a 52 week high of $81.36. The company has a market capitalization of $2.04 billion, a P/E ratio of -21.14 and a beta of 1.29. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.26 and a current ratio of 1.64.

納斯達克:工研院上週五開盤報45.25美元。該股的50日移動均線價格為51.02美元,200日移動均線價格為50.00美元。Itron的52周低點為43.18美元,52周高位為81.36美元。該公司市值20.4億美元,市盈率為-21.14,貝塔係數為1.29。該公司的負債權益比率為0.40,速動比率為1.26,流動比率為1.64。

Itron (NASDAQ:ITRI – Get Rating) last announced its quarterly earnings results on Thursday, August 4th. The scientific and technical instruments company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.21 by ($0.14). Itron had a negative net margin of 5.15% and a positive return on equity of 4.45%. The company had revenue of $431.88 million for the quarter, compared to analyst estimates of $488.53 million. During the same quarter last year, the business earned $0.28 EPS. The company's revenue for the quarter was down 11.8% on a year-over-year basis. On average, research analysts forecast that Itron will post 0.77 EPS for the current fiscal year.
ITRON(納斯達克代碼:ITRI-GET Rating)上一次公佈季度收益是在8月4日星期四。這家科學和技術儀器公司公佈本季度每股收益為0.07美元,低於普遍預期的0.21美元(0.14美元)。ITRON的淨利潤率為負5.15%,股本回報率為正4.45%。該公司本季度營收為4.3188億美元,而分析師預期為4.8853億美元。去年同一季度,該業務每股收益為0.28美元。該公司本季度營收同比下降11.8%。研究分析師平均預測,Itron本財年每股收益將達到0.77歐元。

Insider Activity

內幕活動

In other news, CEO Thomas Deitrich sold 2,605 shares of the firm's stock in a transaction on Tuesday, September 20th. The stock was sold at an average price of $47.66, for a total value of $124,154.30. Following the completion of the sale, the chief executive officer now directly owns 146,997 shares in the company, valued at $7,005,877.02. The sale was disclosed in a filing with the SEC, which is accessible through this link. Over the last ninety days, insiders sold 2,974 shares of company stock worth $141,918. 1.37% of the stock is owned by corporate insiders.

在其他新聞方面,首席執行官託馬斯·德里奇在9月20日星期二的一次交易中出售了2605股該公司的股票。這隻股票的平均售價為47.66美元,總價值為124,154.30美元。出售完成後,首席執行官現在直接擁有該公司146,997股,價值7,005,877.02美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過這個環節。在過去的90天裏,內部人士拋售了2974股公司股票,價值141,918美元。1.37%的股份由企業內部人士持有。

Institutional Trading of Itron

ITRON的機構交易

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Federated Hermes Inc. increased its stake in shares of Itron by 35.2% in the second quarter. Federated Hermes Inc. now owns 841,344 shares of the scientific and technical instruments company's stock valued at $41,587,000 after buying an additional 218,861 shares in the last quarter. Guinness Asset Management LTD increased its position in Itron by 2.2% in the second quarter. Guinness Asset Management LTD now owns 517,040 shares of the scientific and technical instruments company's stock worth $25,557,000 after purchasing an additional 10,927 shares during the period. Guinness Atkinson Asset Management Inc increased its position in Itron by 5.9% in the second quarter. Guinness Atkinson Asset Management Inc now owns 15,190 shares of the scientific and technical instruments company's stock worth $751,000 after purchasing an additional 846 shares during the period. Amundi increased its position in Itron by 345.3% in the second quarter. Amundi now owns 889,826 shares of the scientific and technical instruments company's stock worth $43,979,000 after purchasing an additional 689,990 shares during the period. Finally, Legal & General Group Plc increased its position in Itron by 2.2% in the second quarter. Legal & General Group Plc now owns 269,621 shares of the scientific and technical instruments company's stock worth $13,327,000 after purchasing an additional 5,740 shares during the period. 97.36% of the stock is currently owned by institutional investors and hedge funds.

一些對衝基金和其他機構投資者最近改變了他們在該業務中的頭寸。聯合愛馬仕公司在第二季度增持了35.2%的Itron股票。聯合愛馬仕公司目前持有這家科學和技術儀器公司841,344股股票,價值41,587,000美元,上個季度又購買了218,861股。吉尼斯資產管理有限公司在第二季度將其在Itron的頭寸增加了2.2%。吉尼斯資產管理有限公司在此期間又購買了10,927股,現在擁有517,040股這家科學和技術儀器公司的股票,價值25,557,000美元。吉尼斯·阿特金森資產管理公司第二季度將其在Itron的頭寸增加了5.9%。吉尼斯·阿特金森資產管理公司(Guinness Atkinson Asset Management Inc.)在此期間額外購買了846股,現在擁有這家科學和技術儀器公司15,190股票,價值75.1萬美元。阿蒙迪在第二季度將其在Itron的頭寸增加了345.3。Amundi現在擁有這家科學和技術儀器公司的889,826股股票,價值43,979,000美元,在此期間又購買了689,990股。最後,Legal&General Group Plc在第二季度將其在Itron的頭寸增加了2.2%。Legal&General Group Plc在此期間又購買了5740股,現在擁有269,621股這家科學和技術儀器公司的股票,價值13,327,000美元。97.36%的股票目前由機構投資者和對衝基金持有。

About Itron

關於ITRON

(Get Rating)

(獲取評級)

Itron, Inc, a technology and service company, provides end-to-end solutions that help manage operations in the energy, water, and smart city space worldwide. The company operates through three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing.

Itron,Inc.是一家技術和服務公司,提供端到端解決方案,幫助管理全球能源、水和智能城市空間的運營。該公司通過三個部門運營:設備解決方案、網絡解決方案和結果。設備解決方案部門提供用於測量、控制或傳感的硬件產品。

Read More

閲讀更多內容

  • Get a free copy of the StockNews.com research report on Itron (ITRI)
  • What Steelcase's Earnings Say About the Return to the Office?
  • The Institutions Hold On To Darden Restaurants International
  • Is The Golden Age Of Homebuilding Already Over?
  • These 3 Big Dividend Payers Also Boast Strong Price Growth
  • Natural Gas Prices Continue To Rally, These Stocks Should Benefit
  • 免費獲取StockNews.com關於ITRon的研究報告(ITRI)
  • 斯蒂爾凱斯的收益説明瞭他重返辦公室的原因嗎?
  • 這些機構持有達頓餐飲國際公司的股份
  • 住房建設的黃金時代已經結束了嗎?
  • 這三大股利支付者也擁有強勁的價格增長
  • 天然氣價格繼續回升,這些股票應該會受益

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.

接受Itron Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊,接收對Itron和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論